We transfected T47D breast cancer cells with S6K2 siRNA or control non-targeting siRNA and focused on those differentially expressed genes (DEG) that were increased more than 2-fold using both DESeq [15] and Cuffdiff [16] and a false discovery rate (FDR) of less than 0.05. This evidence concerns the gene RPS6KB2 and breast carcinoma.